Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Integrating bioinformatic analysis and detailed experiments reveal an EMT-related biomarker for clear cell renal cell carcinoma.
Cancer Med. 2023 Sep;12(18):19320-19336. doi: 10.1002/cam4.6504. Epub 2023 Sep 7.
Cancer Med. 2023.
PMID: 37676078
Free PMC article.
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.
Li L, Zeng X, Chao Z, Luo J, Guan W, Zhang Q, Ge Y, Wang Y, Xiong Z, Ma S, Zhou Q, Zhang J, Tian J, Horne D, Yuh B, Hu Z, Wei GH, Wang B, Zhang X, Lan P, Wang Z.
Li L, et al.
Adv Sci (Weinh). 2023 Sep;10(27):e2301975. doi: 10.1002/advs.202301975. Epub 2023 Aug 1.
Adv Sci (Weinh). 2023.
PMID: 37526345
Free PMC article.
Item in Clipboard
VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells.
Ma X, Tan Z, Zhang Q, Ma K, Xiao J, Wang X, Wang Y, Zhong M, Wang Y, Li J, Zeng X, Guan W, Wang S, Gong K, Wei GH, Wang Z.
Ma X, et al.
Cell Biosci. 2022 May 3;12(1):52. doi: 10.1186/s13578-022-00790-x.
Cell Biosci. 2022.
PMID: 35505422
Free PMC article.
Item in Clipboard
Cite
Cite